REJOINDER: Clarification on C4C’s Homoeopathic Milestone
Dear Sir,
The management of C4C Group of Companies wishes to issue a sincere apology and clarification regarding a statement made during the recent launch of our FDA-approved homeopathic medicine to be made available to leading pharmacies for the access of the general public.
In our excitement to share this significant achievement during the World Homoeopathy Week Celebration, it was erroneously stated, that C4C Pharmaceuticals introduced the first FDA approved over the counter Homeopathic Medicine.
We acknowledge that this claim was inaccurate and regret any confusion or oversight it may have caused.
Having been corrected by the FDA that this statement is not accurate and disparaging, we wish to indicate that other Homeopathic Medicines have been registered by the FDA and C4C is not the first to register a homeopathic medicine.
Please note that our products are not registered as Over the Counter Medications.
Indeed, our intention was never to disregard regulations but to celebrate a milestone in our own journey toward improving holistic healthcare access in the country.
The public should be assured that we remain committed to transparency, collaboration, and upholding the standards set by the Food and Drugs Authority and other regulators.
We thank all stakeholders for their continued support and understanding.
Looking forward to having this rejoinder published with all the prominence it deserves in your newspaper.
Thank you.
Signed
— C4C Group of Companies
Cc: Chief Executive
Food and Drugs Authority
About The Author
